← Back
$TARS All transactions

Tarsus Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$47K

Shares

557

Price

$84

Filed

Dec 30

Insider

Name

Azamian Bobak R.

Title

President/CEO and Board Chair

CIK

0001827672

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-24

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

857,991

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $81.89 to $82.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $83.14 to $84.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001827672-25-000007

Form Type

4

Issuer CIK

0001819790

Azamian Bobak R.'s History

Date Ticker Type Value
2025-12-24 TARS $449K
2025-12-24 TARS $47K
2025-12-04 TARS G $0
2025-09-24 TARS $332K
2025-08-11 TARS $300K

Other Insiders at TARS (90d)

Insider Bought Sold Last
Neervannan Seshadri
Chief Operating Officer
$200K 2026-03-20